rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    EW
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Edwards Lifesciences: Momentum Returns, But Valuation Warrants Caution (NYSE:EW)
      12h agoSeeking AlphaEW
      Are Wall Street Analysts Predicting Edwards Lifesciences Stock Will Climb or Sink?
      Nov 16BarchartEW
      $1000 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
      Nov 16BenzingaEW
      Is There Any Reason To Invest In Edwards Lifesciences Stock?
      Nov 14Yahoo FinanceEW
      Edwards Lifesciences stock hits 52-week high at 105.39 USD
      Nov 11Investing.comEW
      Edwards Lifesciences CVP sells $64,530 in shares
      Nov 11Investing.comEW
      Edwards Lifesciences stock rating maintained at Buy by TD Cowen
      Nov 9Investing.comEW
      Edwards Lifesciences Q3 Earnings Call Highlights
      Nov 7Yahoo FinanceEW
      Edwards bumps up sales forecast on TAVR strength in Q3
      Nov 5Yahoo FinanceEW
      Edwards Lifesciences stock rating reiterated at Buy by TD Cowen
      Nov 5Investing.comEW
      Truist raises Edwards Lifesciences stock price target on TAVR growth
      Nov 5Investing.comEW
      Edwards Lifesciences (EW) Trial Data Points To Earlier TAVR Use In Moderate Aortic Stenosis
      Nov 5Yahoo FinanceEW
      Wells Fargo raises Edwards Lifesciences price target on Q3 beat
      Nov 5Investing.comEW
      Mizuho raises Edwards Lifesciences stock price target on TAVR beat
      Nov 5Investing.comEW
      Edwards Lifesciences Q3 2026 Earnings Call Transcript
      Nov 4BenzingaEW
      Edwards Lifesciences earnings beat by $0.06, revenue topped estimates
      Nov 4Investing.comEW
      Edwards Lifesciences Reports Third Quarter Results
      Nov 4Yahoo FinanceEW
      Edwards Lifesciences (EW) Trial Win Puts Fair Value Back In Focus

      Edwards Lifesciences (EW) is back in focus after new data showed its PASCAL tricuspid repair system outperformed medical therapy in the CLASP II TR trial, with benefits sustained through one year. Recent data and regulatory milestones have come alongside clear momentum in the Edwards Lifesciences share price, with a 1-month share price return of 11.79% and a 1-year total shareholder return of 13.12% on a closing share price of US$95.19 as of 4 November 2026. This suggests investors are...

      Nov 4Yahoo FinanceEW
      Edwards Lifesciences stock hits 52-week high at 98.7 USD
      Nov 4Investing.comEW
      This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
      Nov 4BenzingaEW
      Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
      Nov 3MarketWatchEW
      Edwards Lifesciences earnings on deck: Can trial wins boost TMTT?
      Nov 3Investing.comEW
      Edwards Lifesciences' Progress Data Unlikely to Expand TAVR Market, RBC Says
      Nov 3Yahoo FinanceEW
      Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits

      Edwards Lifesciences (NYSE:EW) highlighted new clinical data for its transcatheter tricuspid repair and transcatheter aortic valve replacement programs, including results from the CLASP IITR trial of the PASCAL system and the PROGRESS trial evaluating TAVR in certain patients with moderate aortic st

      Nov 3Yahoo FinanceEW
      Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains
      Nov 2MarketWatchEW
      CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System
      Nov 2Yahoo FinanceEW
      Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors
      Oct 30MarketWatchEW
      Edwards' Q3 Earnings on the Horizon: What's in the Cards?
      Oct 30Yahoo FinanceEW
      Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key Metrics
      Oct 30Yahoo FinanceEW
      Edwards Lifesciences Stock Continually Innovating Ahead Of Q3 Results (NYSE:EW)

      Edwards Lifesciences earns a buy on FDA approvals, cardiology niche strength, and solid cash flow. Read here for a detailed analysis of EW stock.

      Oct 29Seeking AlphaEW
      Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
      Oct 28MarketWatchEW
      Edwards Lifesciences shares may move 7.6% on earnings report
      Oct 28Investing.comEW
      Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Novavax (NVAX) and Edwards Lifesciences (EW)

      Detailed price information for Incyte Corp (INCY-Q) from The Globe and Mail including charting and trades.

      Oct 28The Globe and MailEW
      TD Cowen reiterates Buy on Edwards Lifesciences stock, $104 target
      Oct 27Investing.comEW
      $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
      Oct 26BenzingaEW
      Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
      Oct 26MarketWatchEW
      Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors
      Oct 23MarketWatchEW
      Does Valve Repair Approval Change The Bull Case For Edwards Lifesciences (EW)?
      Oct 23Yahoo FinanceEW
      Edwards wins FDA approval for tricuspid valve repair device
      Oct 23Yahoo FinanceEW
      Edwards Lifesciences faces stock risk ahead of trial results says Stifel
      Oct 22Investing.comEWSF
      Edwards secures FDA approval for tricuspid valve repair system
      Oct 22Yahoo FinanceEW
      Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA
      Oct 21Yahoo FinanceEW
      Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
      Oct 20MarketWatchEW
      Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors
      Oct 16MarketWatchEW
      FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death - Edwards Lifescience

      Edwards Lifesciences recalls Commander M delivery systems following balloon burst reports and 1 death. Read the FDA alert.

      Oct 16BenzingaEW
      FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death

      The U.S. Food and Drug Administration (FDA) issued a high-risk early alert after Edwards Lifesciences Corp. (NYSE:EW) recalled specific lots of its Commander M delivery systems due to reports of balloons bursting during procedures, resulting in one death and a serious injury. Recall Of Commander M Delivery Systems The delivery systems help implant a replacement mitral heart valve through blood vessels, bypassing the need for open-chest surgery. However, the company received three distinct report

      Oct 16Yahoo FinanceEW
      Edwards’ SAPIEN M3 delivery system linked to patient death in FDA alert
      Oct 16Yahoo FinanceEW
      FDA flags Edwards heart-valve delivery system issue after death, injury
      Oct 15ReutersEW
      Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains
      Oct 15MarketWatchEW
      Baird Adjusts Price Target on Edwards Lifesciences to $90 From $94
      Oct 15Yahoo FinanceEW

      This is the newest page. Registered accounts read further back.